Treatment of Shingles with Valacyclovir and Acyclovir

Introduction to Treatment Options

The American College of Physicians recommends valacyclovir 1 gram three times daily for 7-10 days as the preferred first-line treatment for shingles in immunocompetent adults, offering superior convenience with equivalent or better efficacy compared to acyclovir 1

Valacyclovir requires only 3 doses per day, making it significantly more convenient and likely to improve adherence compared to acyclovir's 5 doses per day 1
The Centers for Disease Control and Prevention suggests that treatment should continue until all lesions have completely scabbed, not just for an arbitrary 7-day period 1

The Infectious Diseases Society of America recommends intravenous acyclovir 10 mg/kg every 8 hours for disseminated or invasive herpes zoster in immunocompromised patients, not oral therapy 1
Treatment duration for immunocompromised patients extends beyond standard 7-10 days as lesions develop over 7-14 days and heal more slowly 2

The key clinical endpoint is complete scabbing of all lesions, not calendar days, as recommended by the American Academy of Dermatology 1
Monitor for new lesion formation—immunocompetent patients typically stop forming new lesions after 4-6 days, while immunocompromised patients may continue for 7-14 days 2

Both valacyclovir and acyclovir are well tolerated with similar adverse event profiles, according to the Journal of Clinical Virology 3
Most common side effects are headache and nausea, occurring in <10% of patients, as reported by the Journal of Clinical Virology 3
No serious adverse events were reported in clinical trials comparing the two agents, as stated in the Journal of Clinical Virology 3
Resistance remains rare (<0.5%) in immunocompetent hosts, according to the Journal of Clinical Virology 3